Patrick W Sullivan1, Vahram H Ghushchyan2,3, Jonathan D Campbell2, Gary Globe4, Bruce Bender5, David J Magid6. 1. Regis University School of Pharmacy, Denver, CO, USA. psulliva@regis.edu. 2. Center for Pharmaceutical Outcomes Research, Department of Clinical Pharmacy, University of Colorado, Aurora, CO, USA. 3. American University of Armenia, Yerevan, Armenia. 4. Amgen, Inc., Thousand Oaks, CA, USA. 5. Department of Pediatrics, National Jewish Health, Denver, CO, USA. 6. Institute for Health Research, Kaiser Permanente Colorado, Denver, CO, USA.
Abstract
BACKGROUND: Accurate assessment of preference-based health-related quality of life is important in determining the value of asthma interventions. OBJECTIVE: To examine the sensitivity and responsiveness of the EQ-5D and the AQL-5D to differences in asthma control measured by the Asthma Control Questionnaire (ACQ-5). METHODS: The Observational Study of Asthma Control and Outcomes was a prospective survey of persistent asthma patients ≥12 years old in Kaiser Colorado. Patients received a survey three times in 1 year, including the ACQ-5, AQL-5D and EQ-5D-3L (including VAS). Censored Least Absolute Deviations (CLAD) and logistic regression were used, controlling for sociodemographics and smoking. RESULTS: There were 6666 completed surveys (1799 individuals completed all three survey waves). After controlling for covariates, each one-point increase in ACQ-5 was associated with a decrease of 0.066, 0.058, 0.074 and 6.12 in EQ-5D(US), EQ-5D(UK), AQL-5D and VAS scores. Uncontrolled asthma (ACQ-5 > 1.5) was associated with a decrease of 0.15, 0.17, 0.11 and 10, respectively (vs. ACQ ≤ 1.5). AQL-5D scores were statistically significantly different across categories of ACQ-5 scores of 0.5 (the minimum clinically important difference [MCID]), while EQ-5D scores were not significant across most categories. The AQL-5D appeared more robust to changes in control over time (responsiveness) compared to EQ-5D-3L. CONCLUSION: The AQL-5D appears more responsive to changes in asthma control over time and more sensitive to detecting differences corresponding to the ACQ-5 MCID than the EQ-5D-3L. Using the EQ-5D-3L without an asthma-specific measure such as the AQL-5D may miss clinically important changes in asthma control.
BACKGROUND: Accurate assessment of preference-based health-related quality of life is important in determining the value of asthma interventions. OBJECTIVE: To examine the sensitivity and responsiveness of the EQ-5D and the AQL-5D to differences in asthma control measured by the Asthma Control Questionnaire (ACQ-5). METHODS: The Observational Study of Asthma Control and Outcomes was a prospective survey of persistent asthma patients ≥12 years old in Kaiser Colorado. Patients received a survey three times in 1 year, including the ACQ-5, AQL-5D and EQ-5D-3L (including VAS). Censored Least Absolute Deviations (CLAD) and logistic regression were used, controlling for sociodemographics and smoking. RESULTS: There were 6666 completed surveys (1799 individuals completed all three survey waves). After controlling for covariates, each one-point increase in ACQ-5 was associated with a decrease of 0.066, 0.058, 0.074 and 6.12 in EQ-5D(US), EQ-5D(UK), AQL-5D and VAS scores. Uncontrolled asthma (ACQ-5 > 1.5) was associated with a decrease of 0.15, 0.17, 0.11 and 10, respectively (vs. ACQ ≤ 1.5). AQL-5D scores were statistically significantly different across categories of ACQ-5 scores of 0.5 (the minimum clinically important difference [MCID]), while EQ-5D scores were not significant across most categories. The AQL-5D appeared more robust to changes in control over time (responsiveness) compared to EQ-5D-3L. CONCLUSION: The AQL-5D appears more responsive to changes in asthma control over time and more sensitive to detecting differences corresponding to the ACQ-5 MCID than the EQ-5D-3L. Using the EQ-5D-3L without an asthma-specific measure such as the AQL-5D may miss clinically important changes in asthma control.
Entities:
Keywords:
AQL-5D; Asthma; EQ-5D; Health-related quality of life; Patient reported outcomes; Preference-based health-related quality of life; Utility
Authors: Marilyn L Moy; Anne L Fuhlbrigge; Karen Blumenschein; Richard H Chapman; Alan J Zillich; Karen M Kuntz; A David Paltiel; Barrett T Kitch; Scott T Weiss; Peter J Neumann Journal: Ann Allergy Asthma Immunol Date: 2004-03 Impact factor: 6.347
Authors: Helen M McTaggart-Cowan; Carlo A Marra; Yaling Yang; John E Brazier; Jacek A Kopec; J Mark FitzGerald; Aslam H Anis; Larry D Lynd Journal: Qual Life Res Date: 2008-02-15 Impact factor: 4.147
Authors: Elizabeth F Juniper; Klas Svensson; Ann-Christin Mörk; Elisabeth Ståhl Journal: Health Qual Life Outcomes Date: 2005-09-16 Impact factor: 3.186
Authors: Martine Hoogendoorn; Mark Oppe; Melinde R S Boland; Lucas M A Goossens; Elly A Stolk; Maureen P M H Rutten-van Mölken Journal: Med Decis Making Date: 2019-05-16 Impact factor: 2.583
Authors: Boglárka L Szentes; Konrad Schultz; Dennis Nowak; Michael Schuler; Larissa Schwarzkopf Journal: BMC Pulm Med Date: 2020-06-13 Impact factor: 3.317
Authors: Diane Whalley; Gary Globe; Rebecca Crawford; Lynda Doward; Eskinder Tafesse; John Brazier; David Price Journal: Health Qual Life Outcomes Date: 2018-08-03 Impact factor: 3.186